Entrada Therapeutics TRDA
NASDAQ TRDA
$6.35 +0.09 (+1.44%)
At close: Sep 30, 2026 · 4:00 PM EDT

Entrada Therapeutics (TRDA) Other Non-Current Assets (2020 - 2026)

Updated

Entrada Therapeutics (TRDA) posted Other Non-Current Assets of $3.29 million for Q2 2026, down 16.7% from $3.95 million a year earlier and unchanged from the prior quarter.

Analysis

Entrada Therapeutics (TRDA) Other Non-Current Assets (2020 - 2026) Analysis & Trends

Since Q4 2020, Entrada Therapeutics has reported Other Non-Current Assets for 21 quarters.

  • Annual Other Non-Current Assets shows a five-year compound annual growth rate of 43.5% (FY2020 to FY2025).
  • In prior years, Entrada Therapeutics' Other Non-Current Assets was $4 million in FY2024 (+1.3%), $3.95 million in FY2023 (-24.2%), $5.21 million in FY2022 (+497.5%) and $872,000 in FY2021 (+61.2%).
  • Quarterly Other Non-Current Assets has run from a low of $872,000 in Q4 2021 to a high of $13.84 million in Q1 2023 over five years.
  • On a year-over-year basis, Other Non-Current Assets has declined in each of the last three quarters, with an average decline of 6.2% over the last eight quarters.
  • The strongest year-over-year quarter for Other Non-Current Assets in the past five years was Q4 2022, with growth of 497.5%; the weakest was Q1 2024, with a decline of 71.5%.
  • According to Business Quant data, Other Non-Current Assets for the three prior quarters was $3.29 million (Q1 2026), $3.29 million (Q4 2025) and $3.95 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 14.27 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 10.73 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 4.75 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 1.25 Bn
10 Entrada Therapeutics 243.74 Mn 243.74 Mn - 3.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.29 Mn
Mar 31, 2026 3.29 Mn
Dec 31, 2025 3.29 Mn
Sep 30, 2025 3.95 Mn
Jun 30, 2025 3.95 Mn
Mar 31, 2025 3.95 Mn
Dec 31, 2024 4.00 Mn
Sep 30, 2024 3.95 Mn
Jun 30, 2024 3.95 Mn
Mar 31, 2024 3.95 Mn
Dec 31, 2023 3.95 Mn
Sep 30, 2023 3.95 Mn
Jun 30, 2023 3.95 Mn
Mar 31, 2023 13.84 Mn
Dec 31, 2022 5.21 Mn
Sep 30, 2022 3.95 Mn
Jun 30, 2022 3.95 Mn
Mar 31, 2022 3.95 Mn
Dec 31, 2021 872,000.00
Sep 30, 2021 2.97 Mn
API Access

Entrada Therapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=TRDA&period=max&api_key=YOUR_API_KEY